Melanoma Cells Treated with GGTI and IFN-γ Allow Murine Vaccination and Enhance Cytotoxic Response against Human Melanoma Cells

Guillaume Sarrabayrouse, Christine Pich, Raphaël Moriez et al. · 2010

Read Melanoma Cells Treated with GGTI and IFN-γ Allow Murine Vaccination and Enhance Cytotoxic Response against Human Melanoma Cells by Guillaume Sarrabayrouse, Christine Pich, Raphaël Moriez et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009043.txt.

Description

Guillaume Sarrabayrouse and co-authors dressed up melanoma cells so the immune system could see them, in PLOS ONE in 2010. Melanoma cells often hide by showing few flag molecules to T cells. Without those flags, killer T cells pass the cancer by. Two treatments were combined to force the flags back up.

A drug called GGTI plus the signal interferon-gamma restored the cells' visibility. Mice vaccinated with the treated cells mounted stronger defences. Killer responses against human melanoma cells also grew sharper. The approach could turn a patient's own tumour cells into a teaching vaccine.

Catalog record

CREATORGuillaume Sarrabayrouse, Christine Pich, Raphaël Moriez et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009043

Browse the full library · About the Tower of Babel